Monday, October 15, 2018

Youngevity International, Inc. (NASDAQ: YGYI) Expanding HempFX Line through Launch of Two Hemp-Derived Cannabidiol Products

  • November debut of ‘HempFX Hydration – Pure’ and ‘HempFX Hydration – Sleep’ is part of YGYI’s focus on growing its non-THC-based CBD business
  • YGYI is a top omni-direct lifestyle company that in August introduced three new proprietary blends of hemp-derived cannabinoid products which sold out at the corporate convention
  • In its September 2018 investor presentation, YGYI explains the importance of vertical integration in its hemp-based non-THC CBD business using a “field-to-finish” strategy
Youngevity International, Inc. (NASDAQ: YGYI) continues to grow its HempFX line with the scheduled November introduction of two new products: ‘HempFX Hydration – Pure’ and ‘HempFX Hydration – Sleep’. These are tablet-based products that utilize the company’s Y-DR8+ proprietary technology (http://ibn.fm/I69VR).

The ‘HempFX – Pure’ product will be available in tablet form and can be added to water and dissolved as it is consumed. It is designed to offer 25mg of organic, full spectrum and hemp-derived cannabidiol per tablet. Its goal is to offer, in conjunction with its own portable water bottle system, great tasting and reduced-chemicals tap water. It uses the Y-DR8 filter’s activated carbon cloth (ACC) and its portability is designed to fit the “on-the-go” lifestyle.

‘HempFX – Sleep’ is also a tablet-based product in the line designed to offer a restful night’s sleep with the health benefits of CBD. It combines melatonin with hemp-derived cannabidiol oil in a proprietary beverage enhancement tablet.

YGYI is an omni-direct lifestyle company that uses a hybrid of the direct selling model. It also uses e-commerce and social selling. According to its corporate presentation, its significant market segments include skin care, anti-aging, weight loss, brain health and coffee. It is now entering the cannabis market with its HempFX line. YGYI is also planning for global expansion, focusing primarily on Latin American and Asian markets, with its international revenues already growing significantly this year.

Earlier, YGYI debuted three hemp-based products in the line, which sold out pre-production quantities at ETST’s corporate convention last August. The three blends of cannabinoid will be available to consumers in October, including Soothe, Relax and Uplift (http://ibn.fm/8D5wx).

YGYI’s September 2018 Investor Presentation described its strategy of vertically integrating the hemp-based non-THC CBD industry. It stressed the importance of its “field-to-finish” focus, which maximizes its long term goals of achieving top quality control standards and attaining revenue opportunities across the vertical (http://ibn.fm/R1kl7).

For more information, visit the company’s website at www.YGYI.com

About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html